Characterization of response to everolimus in BOLERO-2: a phase. The ASCO Post on Twitter: "BOLERO-3: Everolimus + Trastuzumab. Everolimus Does Not Overcome Trastuzumab Resistance - Medscape.
BOLERO-2 Study: Everolimus-Exemestane Overcomes Al Resistanc. Everolimus did not extend PFS in HER-2–positive breast cancer.
Characterization of response to everolimus in BOLERO-2: a phase III trial of everolimus plus exemestane in postmenopausal women with HR-positive. 10 Feb 2013 SAN ANTONIO—Adding everolimus to exemestane increased progression-free survival in the Phase III BOLERO-2 trial, which researchers say. 15 Dec 2014 Previously released results of the BOLERO-3 study showed the addition of everolimus to trastuzumab and vinorelbine chemotherapy.
HER2 positive BOLERO-3 Clinical Trial: Everolimus in HER2
12 Dec 2014 BOLERO-3: Everolimus + Trastuzumab/Paclitaxel Misses the Mark in 1st-Line HER2 Advanced Breast Cancer http://ow. ly/FOKSp #BCSM #. 16 Dec 2014 SAN ANTONIO — The addition of everolimus (Afinitor, Novartis Data from BOLERO-3, reported at the 2014 annual meeting of the American.
Final Progression-Free Survival Analysis of BOLERO-2: A Phase III
BOLERO-3 - MDLinx. The BOLERO-2 trial: the addition of everolimus to exemestane in the. The combination of the mTOR inhibitor everolimus with the aromatase inhibitor exemestane was evaluated in the randomized Phase III BOLERO-2 trial.
Everolimus Plus Exemestane in Postmenopausal Patients with HR+. Presentaciуn de PowerPoint.
Everolimus for women with trastuzumab-resistant, HER2-positive.
Everolimus (Afinitor) UKMi New Drugs Online Database
BOLERO-3: Prior Therapy. Presented by: Ruth M. O. Regan, MD. Everolimus +. Trastuzumab +. Vinorelbine. (N = 284). Placebo +. Trastuzumab +. Vinorelbine. 23 May 2014 Obstetrics & Gynecology Article: Everolimus for women with HER2-positive, advanced breast cancer (BOLERO-3): a randomised. 14 Apr 2014 F1000Prime Recommended Article: Everolimus for women with HER2-positive, advanced breast cancer (BOLERO-3): a randomised.
Geen opmerkingen:
Een reactie posten
Opmerking: Alleen leden van deze blog kunnen een reactie posten.